EUVIMEDEUVIMED entdecken
Crossref

In Situ Bioorthogonal Repair of the Vascular Endothelium Glycocalyx to Treat Acute Lung Injury

Yao Wang, Rui Qu, Wenxuan Du, Wei Li, Anqi Wang, Zhoujiang Chen, Huile Gao, Di Wu, Fang Geng, Daniel Scherman, Xianwen Wang, Sanjun Shi und 2 weitere

Small · 2024-12 · 20 (49)

DOI: 10.1002/smll.202405092 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, online erschienen am 26.09.2024. Verfasst von Yao Wang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Coarse Cereal Processing (Ministry of Agriculture and Rural Affairs), School of Food and Biological Engineering, Chengdu University…. Hauptthemen laut MEDLINE: Glycocalyx, Acute Lung Injury, Heparan Sulfate, Endothelium, Vascular. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Key Research and Development projects of Sichuan Province, Sichuan Science and Technology Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In acute lung injury, destruction of the lung endothelial glycocalyx leads to vessel permeabilization and contributes to pulmonary edema and inflammation. Heparan sulfate, which accounts for >70% of glycosaminoglycans in the endothelial glycocalyx, plays a crucial physiological anti‐inflammatory role. To treat acute lung injury, it is explored whether a two‐step in vivo bioorthogonal chemistry strategy can covalently link intravenously administered heparan sulfate to the lung vascular endothelium and the damaged glycocalyx. First, fusogenic liposomes (EBP‐Tz‐FLs) carrying the reactive group tetrazine (Tz), and an E‐selectin‐binding peptide (EBP) to target the lung inflammatory endothelium are administered intravenously. This step aimed to anchor the tetrazine group to the membrane of inflammatory endothelial cells. Second, heparan sulfate (HS‐TCO) conjugated to the trans ‐cyclooctene (TCO) group, which spontaneously reacts with Tz, is injected intravenously, leading to covalent heparan sulfate addition to the vascular endothelium. In a mouse model of acute lung injury, this approach substantially reduced vascular permeability and attenuated lung tissue infiltration. The EBP‐Tz‐FLs and HS‐TCO showed favorable biocompatibility and safety both in vitro and in vivo. The proposed strategy shows good promise in acute lung injury therapy and covalently anchoring functional molecules onto the membrane of target cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlycocalyxAcute Lung InjuryHeparan SulfateEndothelium, VascularAnimalsMiceLiposomesHumansMice, Inbred C57BLLung

Stichwörter der Autor:innen

acute lung injurybioorthogonal chemistryendothelial glycocalyxfusogenic liposomesin vivo targeting

Substanzen

Heparan SulfateLiposomes

Autor:innen und Institutionen

  • Key Laboratory of Coarse Cereal Processing (Ministry of Agriculture and Rural Affairs), School of Food and Biological Engineering, Chengdu University, Chengdu, 610106, China.
  • Sichuan Industrial Institute of Antibiotics, School of Pharmacy, Chengdu University, Chengdu, 610106, China.
  • Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research, Center for Drug Precision Industrial Technology, West Chin…
  • Université Paris Cité, CNRS, Inserm, UTCBS, Paris, 75006, France.
  • School of Biomedical Engineering, Research and Engineering Center of Biomedical Materials, Anhui Medical University, Hefei, 230032, China.
  • State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China.

ORCID-Profile: Hanmei Li

Förderung

  • National Natural Science Foundation of China
  • Key Research and Development projects of Sichuan Province
  • Sichuan Science and Technology Program
  • Young Scientific Talent Foundation of Sichuan Province

Zitieren

APA

Wang, Y., Qu, R., Du, W., Li, W., Wang, A., Chen, Z., Gao, H., Wu, D., Geng, F., Scherman, D., Wang, X., Shi, S., Zou, L., & Li, H. (2024). In Situ Bioorthogonal Repair of the Vascular Endothelium Glycocalyx to Treat Acute Lung Injury. Small, 20(49). https://doi.org/10.1002/smll.202405092

Vancouver

Wang Y, Qu R, Du W, Li W, Wang A, Chen Z, et al. In Situ Bioorthogonal Repair of the Vascular Endothelium Glycocalyx to Treat Acute Lung Injury. Small. 2024;20(49). doi:10.1002/smll.202405092

BibTeX
@article{Wang2024,
  author = {Wang, Yao and Qu, Rui and Du, Wenxuan and Li, Wei and Wang, Anqi and Chen, Zhoujiang and Gao, Huile and Wu, Di and Geng, Fang and Scherman, Daniel and Wang, Xianwen and Shi, Sanjun and Zou, Liang and Li, Hanmei},
  title = {In Situ Bioorthogonal Repair of the Vascular Endothelium Glycocalyx to Treat Acute Lung Injury},
  journal = {Small},
  year = {2024},
  volume = {20},
  number = {49},
  doi = {10.1002/smll.202405092}
}
Kostenlos starten →